Kristian Hastoft Jensen

Reservelæge Onkologisk Klinik, Rigshospitalet, Copenhagen kristian.hastoft.jensen@regionh.dk
Research interests

DK: Alvorlige bivirkninger - herunder særligt infektioner og tidlige dødsfald - i forbindelse med kurativt intenderet strålebehandling af patienter med hoved-hals- og lungekræft.

Læs om Kristians ph.d.-projekt. 

UK: Side effects - in particular infections and early mortality - after curatively intended radiotherapy of head-and-neck and lung cancer patients.

Read more about Kristian's PhD project.

 Workgroups Publications
  • Kristian Hastoft Jensen Ivan Vogelius, Claus Ernst Moser , Elo Andersen, Jesper Grau Eriksen, Jørgen Johansen , Mohammad Farhadi, Maria Andersen, Jens Overgaard, Jeppe Friborg Bloodstream infections in head and neck cancer patients after curative-intent radiotherapy: a population-based study from the Danish Head and Neck Cancer Group database Br J Cancer. 2021 Aug;125(3):458-464 2021
  • Kristian Hastoft Jensen, Ivan Richter Vogelius, Mogens Bernsdorf, Anita Gothelf, Claus Andrup Kristensen, Christian Maare , Elo Andersen, Lena Specht, Jeppe Friborg Early non-cancer mortality risk prediction after curative-intent radiotherapy or chemoradiotherapy for head and neck squamous cell carcinoma Radiother Oncol. 2022 Jun;171:1-6 2022
  • Jensen KH, Vogelius I, Kristensen CA, Andersen E, Overgaard J, Eriksen JG, Primdahl H, Johansen J, Farhadi M, Andersen M, Friborg J Early Mortality after Radical Radiotherapy in Head and Neck Cancer - A Nationwide Analysis from the Danish Head and Neck Cancer Group (DAHANCA) Database. Clin Oncol (R Coll Radiol) . 2020 Jul 19;S0936-6555(20)30286-7. 2020